Conformational Dynamics of α-synuclein: Insights from Mass Spectrometry
Overview
Authors
Affiliations
The aggregation and deposition of α-synuclein in Lewy bodies is associated with the progression of Parkinson's disease. Here, Mass Spectrometry (MS) is used in combination with Ion Mobility (IM), chemical crosslinking and Electron Capture Dissociation (ECD) to probe transient structural elements of α-synuclein and its oligomers. Each of these reveals different aspects of the conformational heterogeneity of this 14 kDa protein. IM-MS analysis indicates that this protein is highly disordered, presenting in positive ionisation mode with a charge state range of 5 ≤z≤ 21 for the monomer, along with a collision cross section range of ∼1600 Å(2). Chemical crosslinking applied in conjunction with IM-MS captures solution phase conformational families enabling comparison with those exhibited in the gas phase. Crosslinking IM-MS identifies 3 distinct conformational families, Compact (∼1200 Å(2)), Extended (∼1500 Å(2)) and Unfolded (∼2350 Å(2)) which correlate with those observed in solution. ECD-Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry (ECD-FT-ICR MS) highlights the effect of pH on α-synuclein structure, identifying the conformational flexibility of the N and C termini as well as providing evidence for structure in the core and at times the C terminus. A hypothesis is proposed for the variability displayed in the structural rearrangement of α-synuclein following changes in solution pH. Following a 120 h aggregation time course, we observe an increase in the ratio of dimer to monomer, but no gross conformational changes in either, beyond the significant variations that are observed day-to-day from this conformationally dynamic protein.
Bakels S, Daly S, Dogan B, Baerenfaenger M, Commandeur J, Rijs A Anal Chem. 2024; .
PMID: 39150274 PMC: 11359389. DOI: 10.1021/acs.analchem.4c02749.
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson's patients.
De Boni L, Wallis A, Watson A, Ruiz-Riquelme A, Leyland L, Bourinaris T EMBO Mol Med. 2024; 16(7):1657-1674.
PMID: 38839930 PMC: 11250827. DOI: 10.1038/s44321-024-00083-5.
Top/Middle-Down Characterization of α-Synuclein Glycoforms.
Miller S, Jeanne Dit Fouque K, Hard E, Balana A, Kaplan D, Voinov V Anal Chem. 2023; 95(49):18039-18045.
PMID: 38047498 PMC: 10836061. DOI: 10.1021/acs.analchem.3c02405.
The role of solvation on the conformational landscape of α-synuclein.
Cheung See Kit M, Cropley T, Bleiholder C, Chouinard C, Sobott F, Webb I Analyst. 2023; 149(1):125-136.
PMID: 37982746 PMC: 10760066. DOI: 10.1039/d3an01680c.
Lipid-induced polymorphic amyloid fibril formation by α-synuclein.
Singh B, Morris R, Kunath T, MacPhee C, Horrocks M Protein Sci. 2023; 32(10):e4736.
PMID: 37515406 PMC: 10521247. DOI: 10.1002/pro.4736.